본문 바로가기
KERD
논문KCI 등재

Regulation of the Hippo signaling pathway by ubiquitin modification

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류화학

초록

The Hippo signaling pathway plays an essential role in adult tissue homeostasis and organ size control. Abnormal regulation of Hippo signaling can be a cause for multiple types of human cancers. Since the awareness of the importance of the Hippo signaling in a wide range of biological fields has been continually grown, it is also understood that a thorough and well-rounded comprehension of the precise dynamics could provide fundamental insights for therapeutic applications. Several components in the Hippo signaling pathway are known to be targeted for proteasomal degradation via ubiquitination by E3 ligases. β-TrCP is a well-known E3 ligase of YAP/TAZ, which leads to the reduction of YAP/TAZ levels. The Hippo signaling pathway can also be inhibited by the E3 ligases (such as ITCH) which target LATS1/2 for degradation. Regulation via ubiquitination involves not only complex network of E3 ligases but also deubiquitinating enzymes (DUBs), which remove ubiquitin from its targets. Interestingly, non-degradative ubiquitin modifications are also known to play important roles in the regulation of Hippo signaling. Although there has been much advanced progress in the investigation of ubiquitin modifications acting as regulators of the Hippo signaling pathway, research done to date still remains inadequate due to the sheer complexity and diversity of the subject. Herein, we review and discuss recent developments that implicate ubiquitin-mediated regulatory mechanisms at multiple steps of the Hippo signaling pathway.

Abstract

The Hippo signaling pathway plays an essential role in adult tissue homeostasis and organ size control. Abnormal regulation of Hippo signaling can be a cause for multiple types of human cancers. Since the awareness of the importance of the Hippo signaling in a wide range of biological fields has been continually grown, it is also understood that a thorough and well-rounded comprehension of the precise dynamics could provide fundamental insights for therapeutic applications. Several components in the Hippo signaling pathway are known to be targeted for proteasomal degradation via ubiquitination by E3 ligases. β-TrCP is a well-known E3 ligase of YAP/TAZ, which leads to the reduction of YAP/TAZ levels. The Hippo signaling pathway can also be inhibited by the E3 ligases (such as ITCH) which target LATS1/2 for degradation. Regulation via ubiquitination involves not only complex network of E3 ligases but also deubiquitinating enzymes (DUBs), which remove ubiquitin from its targets. Interestingly, non-degradative ubiquitin modifications are also known to play important roles in the regulation of Hippo signaling. Although there has been much advanced progress in the investigation of ubiquitin modifications acting as regulators of the Hippo signaling pathway, research done to date still remains inadequate due to the sheer complexity and diversity of the subject. Herein, we review and discuss recent developments that implicate ubiquitin-mediated regulatory mechanisms at multiple steps of the Hippo signaling pathway.

참고문헌 (73)

  1. Meng Z, "Mechanisms of Hippo pathway regulation", Genes Dev, 30, pp.1~17 (2016)[DOI]
  2. Zanconato F, "YAP", TAZ at the Roots of Cancer, 2016, pp.29, 783~803
  3. Hershko A, "The ubiquitin system", Annu Rev Biochem, 67, pp.425~479 (1998)[DOI]
  4. Koegl M, "A novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly", Cell, 96, pp.635~644 (1999)[DOI]
  5. Ikeda F, "Atypical ubiquitin chains: new molecular signals. 'Protein Modifications: Beyond the Usual Suspects' review series", EMBO Rep, 9, pp.536~542 (2008)[DOI]
  6. Kirisako T, "A ubiquitin ligase complex assembles linear polyubiquitin chains", EMBO J, 25, pp.4877~4887 (2006)[DOI]
  7. Li W, "Genome-wide and functional annotation of human E3 ubiquitin ligases identifies MULAN, a mitochondrial E3 that regulates the organelle's dynamics and signaling", PLoS One, 3, pp.e1487~ (2008)[DOI]
  8. Nijman SM, "A genomic and functional inventory of deubiquitinating enzymes", Cell, 123, pp.773~786 (2005)[DOI]
  9. Canning M, "A RING finger ubiquitin ligase is protected from autocatalyzed ubiquitination and degradation by binding to ubiquitin-specific protease USP7", J Biol Chem, 279, pp.38160~38168 (2004)[DOI]
  10. Wu X, "Stabilization of the E3 ubiquitin ligase Nrdp1 by the deubiquitinating enzyme USP8", Mol Cell Biol, 24, pp.7748~7757 (2004)[DOI]
  11. Hetfeld BK, "The zinc finger of the CSN-associated deubiquitinating enzyme USP15 is essential to rescue the E3 ligase Rbx1", Curr Biol, 15, pp.1217~1221 (2005)[DOI]
  12. Brooks CL, "The p53--Mdm2--HAUSP complex is involved in p53 stabilization by HAUSP", Oncogene, 26, pp.7262~7266 (2007)[DOI]
  13. Trompouki E, "CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members", Nature, 424, pp.793~796 (2003)[DOI]
  14. Wertz IE, "De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling", Nature, 430, pp.694~699 (2004)[DOI]
  15. Liu CY, "The hippo tumor pathway promotes TAZ degradation by phosphorylating a phosphodegron and recruiting the SCF{beta}-TrCP E3 ligase", J Biol Chem, 285, pp.37159~37169 (2010)[DOI]
  16. Zhao B, "A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP)", Genes Dev, 24, pp.72~85 (2010)[DOI]
  17. Huang W, "The N-terminal phosphodegron targets TAZ", WWTR1 protein for SCFbeta-TrCP-dependent degradation in response to phosphatidylinositol 3-kinase inhibition, 2012, pp.287, 26245~26253
  18. Tu K, "Fbxw7 is an independent prognostic marker and induces apoptosis and growth arrest by regulating YAP abundance in hepatocellular carcinoma", Mol Cancer, 13, pp.110~ (2014)[DOI]
  19. Wang W, "PTPN14 is required for the density-dependent control of YAP1", Genes Dev, 26, pp.1959~1971 (2012)[DOI]
  20. Chan SW, "Hippo pathway-independent restriction of TAZ and YAP by angiomotin", J Biol Chem, 286, pp.7018~7026 (2011)[DOI]
  21. Wang W, "Angiomotin-like proteins associate with and negatively regulate YAP1", J Biol Chem, 286, pp.4364~4370 (2011)[DOI]
  22. Zhao B, "Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein", Genes Dev, 25, pp.51~63 (2011)[DOI]
  23. Wang C, "The Nedd4-like ubiquitin E3 ligases target angiomotin", p130 to ubiquitindependent degradation, 2015, pp.444, 279~289
  24. Wang W, "Tankyrase Inhibitors Target YAP by Stabilizing Angiomotin Family Proteins", Cell Rep, 13, pp.524~532 (2015)[DOI]
  25. Zhang Y, "RNF146 is a poly(ADP-ribose)-directed E3 ligase that regulates axin degradation and Wnt signalling", Nat Cell Biol, 13, pp.623~629 (2011)[DOI]
  26. Thanh Nguyen H, "Deubiquitylating enzyme USP9x regulates hippo pathway activity by controlling angiomotin protein turnover", Cell Discov, 2, pp.16001~ (2016)
  27. Huang J, "The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP", Cell, 122, pp.421~434 (2005)[DOI]
  28. Lei QY, "TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway", Mol Cell Biol, 28, pp.2426~2436 (2008)[DOI]
  29. Hamaratoglu F, "The tumour-suppressor genes NF2", Merlin and Expanded act through Hippo signalling to regulate cell proliferation and apoptosis, 2006, pp.8, 27~36
  30. Genevet A, "Kibra is a regulator of the Salvador", Warts, Dev Cell, pp.2010, 18[DOI]
  31. Yu J, "Kibra functions as a tumor suppressor protein that regulates Hippo signaling in conjunction with Merlin and Expanded", Dev Cell, 18, pp.288~299 (2010)[DOI]
  32. Visser-Grieve S, "LATS1 tumor suppressor is a novel actin-binding protein and negative regulator of actin polymerization", Cell Res, 21, pp.1513~1516 (2011)[DOI]
  33. Mo JS, "Regulation of the Hippo-YAP pathway by protease-activated receptors (PARs)", Genes Dev, 26, pp.2138~2143 (2012)[DOI]
  34. Yu FX, "Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling", Cell, 150, pp.780~791 (2012)[DOI]
  35. Zhao B, "Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis", Genes Dev, 26, pp.54~68 (2012)[DOI]
  36. Wada K, "Hippo pathway regulation by cell morphology and stress fibers", Development, 138, pp.3907~3914 (2011)[DOI]
  37. Chen HI, "The WW domain of Yes-associated protein binds a proline-rich ligand that differs from the consensus established for Src homology 3-binding modules", Proc Natl Acad Sci U S A, 92, pp.7819~7823 (1995)[DOI]
  38. "Proc Natl Acad Sci U S A", 2011, 4870~4875, 10.1073[DOI]
  39. Salah Z, "Negative regulation of the Hippo pathway by E3 ubiquitin ligase ITCH is sufficient to promote tumorigenicity", Cancer Res, 71, pp.2010~2020 (2011)[DOI]
  40. Salah Z, "NEDD4 E3 ligase inhibits the activity of the Hippo pathway by targeting LATS1 for degradation", Cell Cycle, 12, pp.3817~3823 (2013)[DOI]
  41. Bae SJ, "NEDD4 controls intestinal stem cell homeostasis by regulating the Hippo signalling pathway", Nat Commun, 6, pp.6314~ (2015)[DOI]
  42. Yeung B, "WWP1 E3 ligase targets LATS1 for ubiquitin-mediated degradation in breast cancer cells", PLoS One, 8, pp.e61027~ (2013)[DOI]
  43. Cao L, "Ubiquitin E3 ligase dSmurf is essential for Wts protein turnover and Hippo signaling", Biochem Biophys Res Commun, 454, pp.167~171 (2014)[DOI]
  44. Li W, "Merlin", NF2 suppresses tumorigenesis by inhibiting the E3 ubiquitin ligase CRL4(DCAF1) in the nucleus, 2010, pp.140, 477~490
  45. Li W, "Merlin", NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus, 2014, pp.26, 48~60
  46. Deng J, "Cullin 4A (CUL4A), a direct target of miR-9 and miR-137, promotes gastric cancer proliferation and invasion by regulating the Hippo signaling pathway", Oncotarget, 7, pp.10037~10050 (2016)
  47. Sang Y, "The role and mechanism of CRL4 E3 ubiquitin ligase in cancer and its potential therapy implications", Oncotarget, 6, pp.42590~42602 (2015)
  48. Ma B, "Hypoxia regulates Hippo signalling through the SIAH2 ubiquitin E3 ligase", Nat Cell Biol, 17, pp.95~103 (2015)
  49. Kim M, "Role of Angiomotin-like 2 mono-ubiquitination on YAP inhibition", EMBO Rep, 17, pp.64~78 (2016)[DOI]
  50. Kim Y, "Deubiquitinase YOD1 potentiates YAP", TAZ activities through enhancing ITCH stability, 2017, pp.114, 4691~4696
  51. Praskova M, "MOBKL1A", MOBKL1B phosphorylation by MST1 and MST2 inhibits cell proliferation, 2008, pp.18, 311~321
  52. Wei X, "Mob as tumor suppressor is activated by Hippo kinase for growth inhibition in Drosophila", EMBO J, 26, pp.1772~1781 (2007)[DOI]
  53. Chan EH, "The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1", Oncogene, 24, pp.2076~2086 (2005)[DOI]
  54. Lignitto L, "Proteolysis of MOB1 by the ubiquitin ligase praja2 attenuates Hippo signalling and supports glioblastoma growth", Nat Commun, 4, pp.1822~ (2013)[DOI]
  55. Tapon N, "salvador Promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines", Cell, 110, pp.467~478 (2002)[DOI]
  56. Callus BA, "Vaux, Association of mammalian sterile twenty kinases, Mst1 and Mst2, with hSalvador via C-terminal coiled-coil domains, leads to its stabilization and phosphorylation", FEBS J, 273, pp.4264~4276 (2006)[DOI]
  57. Lee JH, "A crucial role of WW45 in developing epithelial tissues in the mouse", EMBO J, 27, pp.1231~1242 (2008)[DOI]
  58. Lu L, "Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver", Proc Natl Acad Sci U S A, 107, pp.1437~1442 (2010)[DOI]
  59. Aerne BL, "Hippo Stabilises Its Adaptor Salvador by Antagonising the HECT Ubiquitin Ligase Herc4", PLoS One, 10, pp.e0131113~ (2015)[DOI]
  60. Poon CL, "The sterile 20-like kinase Tao-1 controls tissue growth by regulating the Salvador-Warts-Hippo pathway", Dev Cell, 21, pp.896~906 (2011)[DOI]
  61. Boggiano JC, "Tao-1 phosphorylates Hippo", MST kinases to regulate the Hippo-Salvador-Warts tumor suppressor pathway, 2011, pp.21, 888~895
  62. Praskova M, "Regulation of the MST1 kinase by autophosphorylation, by the growth inhibitory proteins, RASSF1 and NORE1, and by Ras", Biochem J, 381, pp.453~462 (2004)[DOI]
  63. Yuan Z, "Phosphoinositide 3-kinase", Akt inhibits MST1-mediated pro-apoptotic signaling through phosphorylation of threonine 120, 2010, pp.285, 3815~3824
  64. Collak FK, "Threonine-120 phosphorylation regulated by phosphoinositide-3-kinase", Akt and mammalian target of rapamycin pathway signaling limits the antitumor activity of mammalian sterile 20-like kinase 1, 2012, pp.287, 23698~23709
  65. Xiao L, "The c-Abl-MST1 signaling pathway mediates oxidative stress-induced neuronal cell death", J Neurosci, 31, pp.9611~9619 (2011)[DOI]
  66. Chen Y, "CYLD negatively regulates Hippo signaling by limiting Hpo phosphorylation in Drosophila", Biochem Biophys Res Commun, 452, pp.808~812 (2014)[DOI]
  67. Rodriguez-Boulan E, "Morphogenesis of the polarized epithelial cell phenotype", Science, 245, pp.718~725 (1989)[DOI]
  68. Gumbiner BM, "Cell adhesion: the molecular basis of tissue architecture and morphogenesis", Cell, 84, pp.345~357 (1996)[DOI]
  69. Chen CL, "The apical-basal cell polarity determinant Crumbs regulates Hippo signaling in Drosophila", Proc Natl Acad Sci U S A, 107, pp.15810~15815 (2010)[DOI]
  70. Ling C, "The apical transmembrane protein Crumbs functions as a tumor suppressor that regulates Hippo signaling by binding to Expanded", Proc Natl Acad Sci U S A, 107, pp.10532~10537 (2010)[DOI]
  71. Varelas X, "The Crumbs complex couples cell density sensing to Hippo-dependent control of the TGF-beta-SMAD pathway", Dev Cell, 19, pp.831~844 (2010)[DOI]
  72. Robinson BS, "Crumbs regulates Salvador", Warts, Curr Biol, pp.2010, 20[DOI]
  73. Ribeiro P, "Crumbs promotes expanded recognition and degradation by the SCF(Slimb", beta-TrCP) ubiquitin ligase, 2014, pp.111, E1980~E19809

관련 논문AI추천

이 간행물의 다른 논문 (7건)